Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription Articles published in Eur Neurol Retrieve available abstracts of 26 articles: HTML format Text format

Single Articles

January 2012
1. LANG C , Reiss C, Maurer M
   Natalizumab May Improve Cognition and Mood in Multiple Sclerosis.
   Eur Neurol. 2012;67:162-166.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. HUANG CF , Lo CP, Tseng CY, Chen YC, et al
   A Rare 'Palisading' Enhancing Pattern of Multiple Sclerosis.
   Eur Neurol. 2012;67:161.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. ALLALI G , Laidet M, Assal F, Beauchet O, et al
   Adapted Timed Up and Go: A Rapid Clinical Test to Assess Gait and Cognition in Multiple Sclerosis.
   Eur Neurol. 2012;67:116-120.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. MULROY E , Joyce E, Scott J, Melling J, et al
   Long-Term Risk of Leukaemia or Cardiomyopathy after Mitoxantrone Therapy for Multiple Sclerosis.
   Eur Neurol. 2011;67:45-47.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. BAUMGARTNER A , Stich O, Rauer S
   Anaphylactic Reaction after Injection of Glatiramer Acetate (Copaxone(R)) in Patients with Relapsing-Remitting Multiple Sclerosis.
   Eur Neurol. 2011;66:368-370.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. REESE JP , John A, Wienemann G, Wellek A, et al
   Economic Burden in a German Cohort of Patients with Multiple Sclerosis.
   Eur Neurol. 2011;66:311-321.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
7. SHIMIZU Y , Ota K, Kubo S, Kabasawa C, et al
   Association of Th1/Th2-Related Chemokine Receptors in Peripheral T Cells with Disease Activity in Patients with Multiple Sclerosis and Neuromyelitis Optica.
   Eur Neurol. 2011;66:91-97.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
8. AYDAR G , Kurt S, Karaer Unaldi H, Erkorkmaz U, et al
   Restless Legs Syndrome in Multiple Sclerosis.
   Eur Neurol. 2011;65:302-306.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2011
9. YILDIZ M , Tettenborn B, Putzki N
   Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate.
   Eur Neurol. 2011;65:231-232.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. TUMANI H , Kassubek J, Hijazi M, Lehmensiek V, et al
    Patterns of Th1/Th2 Cytokines Predict Clinical Response in Multiple Sclerosis Patients Treated with Glatiramer Acetate.
    Eur Neurol. 2011;65:164-169.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
11. CARMONA O , Masuet C, Alia P, Moral E, et al
    Apolipoprotein Alleles and the Response to Interferon-beta-1b in Multiple Sclerosis.
    Eur Neurol. 2011;65:132-137.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. TANAKA M , Matsui M, Tahara M, Tanaka K, et al
    Low Incidence of Asymptomatic Contrast-Enhancing Brain Lesions in Japanese Patients with Multiple Sclerosis.
    Eur Neurol. 2011;65:119-122.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
13. ARROYO E , Grau C, Ramo-Tello C, Parra J, et al
    Adherence to Disease-Modifying Therapies in Spanish Patients with Relapsing Multiple Sclerosis: Two-Year Interim Results of the Global Adherence Project.
    Eur Neurol. 2011;65:59-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. WANG KC , Tsai CP, Lee CL, Chen SY, et al
    The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
    Eur Neurol. 2011;65:99-104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
15. ZECCA C , Petrini L, Limoni C, Staedler C, et al
    Tolerability and Acceptance of Prolonged Low/Delayed Mitoxantrone Regimens in Patients with Worsening Multiple Sclerosis.
    Eur Neurol. 2010;65:40-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
16. BRISSART H , Sauvee M, Latarche C, Dillier C, et al
    Integration of Cognitive Impairment in the Expanded Disability Status Scale of 215 Patients with Multiple Sclerosis.
    Eur Neurol. 2010;64:345-350.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SAHRAIAN MA , Khorramnia S, Ebrahim MM, Moinfar Z, et al
    Multiple Sclerosis in Iran: A Demographic Study of 8,000 Patients and Changes over Time.
    Eur Neurol. 2010;64:331-336.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
18. KOUTSIS G , Evangelopoulos ME, Andreadou E, Mandellos D, et al
    The Onset of Multiple Sclerosis in Greece: A Single-Center Study of 1,034 Consecutive Patients.
    Eur Neurol. 2010;63:350-356.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
19. HUFSCHMIDT A , Shabarin V, Rauer S, Zimmer T, et al
    Neurological Symptoms Accompanying Urinary Tract Infections.
    Eur Neurol. 2010;63:180-183.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. MATSUI M , Tahara M, Tanaka M, Tanaka K, et al
    CD8CD11a(high) Cells Decreased in Multiple Sclerosis but Not in Neuromyelitis Optica.
    Eur Neurol. 2010;63:159-163.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
21. BURGETOVA A , Seidl Z, Krasensky J, Horakova D, et al
    Multiple Sclerosis and the Accumulation of Iron in the Basal Ganglia: Quantitative Assessment of Brain Iron Using MRI T(2) Relaxometry.
    Eur Neurol. 2010;63:136-143.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. PUTZKI N , Yaldizli O, Buhler R, Schwegler G, et al
    Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland.
    Eur Neurol. 2010;63:101-106.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ARTEMIADIS AK , Anagnostouli MC
    Apoptosis of Oligodendrocytes and Post-Translational Modifications of Myelin Basic Protein in Multiple Sclerosis: Possible Role for the Early Stages of Multiple Sclerosis.
    Eur Neurol. 2010;63:65-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. PUTZKI N , Baranwal MK, Tettenborn B, Limmroth V, et al
    Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells.
    Eur Neurol. 2010;63:311-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. REINHARD M , Rosengarten B, Kirchhoff L, Hetzel A, et al
    Natalizumab and regulation of cerebral blood flow: results from an observational study.
    Eur Neurol. 2010;64:124-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. YILDIZ M , Tettenborn B, Putzki N
    Natalizumab and beyond.
    Eur Neurol. 2010;64:236-40.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: